Pano Therapeutics
PrivateCompany Overview
Pano Therapeutics operates in Healthcare & Life Sciences and is based in San Francisco, California. It was founded in 2017.
Pano Therapeutics is a preclinical-stage biotechnology company that develops CNS-optimized biguanide small molecule drugs for the treatment of neurodevelopmental disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pano Therapeutics Comparables
Compare Pano Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Connecta Therapeutics | 79% | |
| Morningside | 79% | |
| Autifony Therapeutics Limited | 77% |
For institutional investors. Book with your work email.
Pano Therapeutics Funding Rounds
Historical fundraising activity
Pano Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baszucki Group | Seed |
| Longevitytech.fund | Seed |
| Western Technology Investment | Seed |
Pano Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pano Therapeutics's valuation, stock price, and market status.
Is Pano Therapeutics a public or private company?
Pano Therapeutics is a private company.
What is the current stock price of Pano Therapeutics?
Pano Therapeutics is a private company, so its shares have no public market price. Caplight tracks Pano Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pano Therapeutics worth (valuation)?
Valuation information for Pano Therapeutics is not publicly available.
Can I buy Pano Therapeutics stock?
Pano Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pano Therapeutics's last funding round?
Funding round information for Pano Therapeutics is not publicly available.
Who are the main investors in Pano Therapeutics?
Key investors in Pano Therapeutics include Baszucki Group, Longevitytech.fund, Western Technology Investment.
Will Pano Therapeutics IPO soon?
No public IPO plans have been announced for Pano Therapeutics.
How can I track Pano Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Pano Therapeutics's shares on secondary markets.